Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.19 by 110.53 percent. This is a 108 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $74.877 million which missed the analyst consensus estimate of $105.804 million by 29.23 percent. This is a 28.05 percent decrease over sales of $104.061 million the same period last year.
Ironwood Pharmaceuticals Q1 2024 Adj EPS $(0.02) Misses $0.19 Estimate, Sales $74.877M Miss $105.804M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.